We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00166179
First Posted: September 14, 2005
Last Update Posted: September 26, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Randolph E Patterson, Emory University
September 13, 2005
September 14, 2005
September 26, 2014
November 2003
October 2006   (Final data collection date for primary outcome measure)
Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI [ Time Frame: time of initial scans ]
Not Provided
Complete list of historical versions of study NCT00166179 on ClinicalTrials.gov Archive Site
Compare size of regions of viable and non viable myocardium as % left ventricle by MRI vs. PET [ Time Frame: at time of initial scans ]
Not Provided
Not Provided
Not Provided
 
Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI
Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI
The purpose of this study is to compare cardiac MRI with positron emission tomography (PET) with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better, than PET with FDG.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Age > 25 yrs, mean + SD = 60.3 + 10.2, 83% male, are patients referred by cardiologist or cardiac surgeon for assessment of myocardial viability by PET FDG.
Coronary Artery Disease
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
57
October 2006
October 2006   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • PET-FDG ordered to assess myocardial viability

Exclusion Criteria:

  • Contraindicated for MRI
  • Pregnant
  • Age <25 yrs
Sexes Eligible for Study: All
18 Years to 95 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00166179
IRB00000292
6-56550 ( Other Identifier: Other )
No
Not Provided
Not Provided
Randolph E Patterson, Emory University
Emory University
Not Provided
Principal Investigator: Randolph Patterson, MD Staff
Emory University
September 2014